发明名称 Amine derivatives, their preparation and pharmaceutical compositions containing them.
摘要 <p>The invention relates to compounds of the general formula (I) &lt;Chemistry id="chema01" num="0001"&gt;&lt;Image id="ia01" he="16" wi="81" file="IMGA0001.TIF" imgContent="chem" imgFormat="TIFF" inline="no" /&gt;&lt;/Chemistry&gt;and physiologically acceptable salts, N-oxides, hydrates and bioprecursors thereof, in which Y represents =0, =S, =CHNO&lt;Sub&gt;2&lt;/Sub&gt; or =NR&lt;Sub&gt;3&lt;/Sub&gt; where R&lt;Sub&gt;3&lt;/Sub&gt; represents hydrogen, nitro, cyano, lower alkyl, aryl, lower alkylsulphonyl or arylsulphonyl; R&lt;Sub&gt;1&lt;/Sub&gt; and R&lt;Sub&gt;2&lt;/Sub&gt;, which may be the same or different, each represent hydrogen lower alkyl, cycloalkyl, lower alkenyl, aralkyl, hydroxy, lower trifluoroalkyl, lower alkyl substituted by hydroxy, lower alkoxy, amine, lower alkylamino or dialkylamino, or R&lt;Sub&gt;1&lt;/Sub&gt; and R&lt;Sub&gt;2&lt;/Sub&gt; together with the nitrogen atom to which they are attached form a 5 to 7 membered heterocyclic ring which may contain other heteroatoms or the group &lt;Chemistry id="chema02" num="0002"&gt;&lt;Image id="ia02" he="12" wi="12" file="IMGA0002.TIF" imgContent="chem" imgFormat="TIFF" inline="no" /&gt;&lt;/Chemistry&gt;where R&lt;Sub&gt;4&lt;/Sub&gt; represents hydrogen or lower alkyl; Q represents a furan or thiophen ring in which incorporation into the rest of the molecule is through bonds at the 2- and 5-positions, or a benzene ring in which incorporation into the rest of the molecule is through bonds at the 1- and 3- or 1- and 4-positions; &lt;UnorderedLists id="ula01" listStyle="none"&gt;&lt;ListItem&gt;X represents-CH&lt;Sub&gt;2&lt;/Sub&gt;-,-O-or-S-;&lt;/ListItem&gt;&lt;ListItem&gt;n represents zero, 1 or 2;&lt;/ListItem&gt;&lt;ListItem&gt;m represents 2, 3 or 4;&lt;/ListItem&gt;&lt;ListItem&gt;Alk represents a straight chain alkylene group of 1 to 3 carbon atoms; (except that n is not zero when X is oxygen and Q is a furan or thiophen ring system)&lt;/ListItem&gt;&lt;ListItem&gt;q represents 2, 3, or 4 or can additionally represent zero or 1 when E is a -CH2-group;&lt;/ListItem&gt;&lt;ListItem&gt;p represents zero, 1 or 2;&lt;/ListItem&gt;&lt;ListItem&gt;E represents-CN&lt;Sub&gt;2&lt;/Sub&gt;-,-O- or -S-; and&lt;/ListItem&gt;&lt;ListItem&gt;Z represents a monocyclic 5 or 6 membered carbocyclic or heterocyclic aromatic ring which may be optionally substituted by one or more groups or Z represents the group &lt;Chemistry id="chema03" num="0003"&gt;&lt;Image id="ia03" he="13" wi="32" file="IMGA0003.TIF" imgContent="chem" imgFormat="TIFF" inline="no" /&gt;&lt;/Chemistry&gt;&lt;!-- EPO &lt;DP n="2"&gt; --&gt; where&lt;/ListItem&gt;&lt;ListItem&gt;Q' represents any of the rings defined for Q;&lt;/ListItem&gt;&lt;ListItem&gt;Alk' represents any of the groups defined for Alk: and R&lt;Sub&gt;5&lt;/Sub&gt; and R&lt;Sub&gt;6&lt;/Sub&gt;, which may be the same or different, each represent any of the groups defined for R&lt;Sub&gt;1&lt;/Sub&gt; and R&lt;Sub&gt;2&lt;/Sub&gt;; (except that p is not zero when E is oxygen and Q' or Z is a furan or thiophen ring system.&lt;/ListItem&gt;&lt;/UnorderedLists&gt;</p><p>The compounds of formula (I) show pharmacological activity as selective histamine H&lt;Sub&gt;2&lt;/Sub&gt;-antagonists.</p>
申请公布号 EP0002930(A1) 申请公布日期 1979.07.11
申请号 EP19780300869 申请日期 1978.12.20
申请人 GLAXO GROUP LIMITED 发明人 MARTIN-SMITH, MICHAEL;PRICE, BARRY JOHN;BRADSHAW, JOHN;CLITHEROW, JOHN WATSON
分类号 A61K31/34;A61K31/341;A61K31/345;A61K31/38;A61K31/381;A61K31/40;A61K31/495;A61K31/505;A61P1/04;C07C67/00;C07C209/00;C07C209/60;C07C211/29;C07C217/48;C07C261/04;C07C275/32;C07C301/00;C07C303/36;C07C303/40;C07C311/64;C07C313/00;C07C323/29;C07C323/44;C07C323/47;C07C323/48;C07C325/00;C07C335/08;C07D209/48;C07D213/32;C07D295/096;C07D307/28;C07D307/38;C07D307/52;C07D333/20;C07D405/12;C07D409/12;(IPC1-7):07D307/52;07D333/20;07C157/02;07C129/08;61K31/38;61K31/34;61K31/17;61K31/13;07D405/12;07D409/12;07C127/00 主分类号 A61K31/34
代理机构 代理人
主权项
地址